Immunomodulators are chemicals product that are used to support immune function by altering the immune system’s response in order to threat in a favorable way. They are classified into immunosuppressants and immunostimulants.
Hoffmann-La Roche Ltd., Biogen Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Amgen, Inc., Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., Eli Lilly and Company, Abbott Laboratories, Johnson & Johnson, and Pfizer Inc.
Request Free Sample Copy With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-sample/4609
Growing prevalence of multiple sclerosis is driving growth of the immunomodulators market. According to the Future Medicine, an estimated 2.3 million people live with MS worldwide. In North America, the prevalence is 140 cases per 100,000 population; approximately 70% of people with MS are women. Among adults 20–40 years of age, the ratio of women to men with MS has increased from 2:1 to 3:1 in the last 30 years
Increasing clinical trials for the development of immunotherapeutic agent is also projected to augment immunomodulators market growth.
Covid-19 Impact Analysis
The outbreak of COVID-19 is likely to have favorable impact on the industry in the near future, owing to growing sales of immunomodulating products.
The immunomodulators market is expected to exhibit a CAGR of XX % over the forecast period owing to the increasing need to treat autoimmune diseases such as rheumatoid arthritis is driving demand for immunomodulators.
North America is expected to witness significant growth over the forecast period owing to the growing launch of new product in For instance, in August 2019, AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved RINVOQ™ (upadacitinib), a 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate (MTX-IR)
Request PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4609
Global Immunomodulators Market, By Product Type:
- Calcineurin Inhibitors
Global Immunomodulators Market, By Application:
Global Immunomodulators Market, By End User:
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Immunomodulators Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Immunomodulators Industry Impact
Chapter 2 Immunomodulators Competition by Types, Applications, and Top Regions and Countries
2.1 Immunomodulators (Volume and Value) by Type
2.3 Immunomodulators (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Immunomodulators Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Immunomodulators Market Analysis
Chapter 6 East Asia Immunomodulators Market Analysis
Chapter 7 Europe Immunomodulators Market Analysis
Chapter 8 South Asia Immunomodulators Market Analysis
Chapter 9 Southeast Asia Immunomodulators Market Analysis
Chapter 10 Middle East Immunomodulators Market Analysis
Chapter 11 Africa Immunomodulators Market Analysis
Chapter 12 Oceania Immunomodulators Market Analysis
Chapter 13 South America Immunomodulators Market Analysis
Chapter 14 Company Profiles and Key Figures in Immunomodulators Business
Chapter 15 Immunomodulators Market Forecast (2021-2027)
Chapter 16 Conclusions
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Buy This Complete Business Report @
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Senior Client Partner – Business Development
Coherent Market Insights